Stifel starts Lexeo at buy, cites ataxia and Alzheimer’s drug candidates (LXEO) Markets December 1, 2023 ismagilov Stifel has began protection of newly public Lexeo Therapeutics (NASDAQ:LXEO) with a purchase ranking, saying it was bullish on…
ServiceNow likely had ‘strong’ finish to Q2, Stifel says (NYSE:NOW) Markets July 10, 2023 Sundry Images/iStock Editorial by way of Getty Photographs Software program firm ServiceNow (NYSE:NOW) possible had a “sturdy” end to the…
